DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /EpigeneticsEpigenetics
  5. /SirtuinSirtuin
  6. /RencofilstatRencofilstat
Chemical structure of CAS 1383420-08-3

Rencofilstat

CAS No.1383420-08-3
MDL No.N/A
MFC67H122N12O13
MW1303.80
InChI KeyKBARHGHBFILILC-NGIJKBHDSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1383420-08-3
Product NameRencofilstat

Associated Conditions

hepatocellular carcinoma·non-alcoholic fatty liver disease
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models.

The Journal of pharmacology and experimental therapeutics • Vol. 371, Issue 2 • 2019
PMID: 31406003PMC: PMC6815936DOI: 10.1124/jpet.119.261099

Development, Characterization, and Pharmacokinetic Evaluation of a CRV431 Loaded Self-Microemulsifying Drug Delivery System.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques • Vol. 21, Issue 1s • 2018
PMID: 30472978DOI: 10.18433/jpps30245

In Vitro Phase I Metabolism of CRV431, a Novel Oral Drug Candidate for Chronic Hepatitis B.

Pharmaceutics • Vol. 9, Issue 4 • 2017
PMID: 29120380PMC: PMC5750657DOI: 10.3390/pharmaceutics9040051

The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of Action.

PloS one • Vol. 10, Issue 8 • 2015
PMID: 26263487PMC: PMC4532424DOI: 10.1371/journal.pone.0134707

Documentation

Similar Products

  • Alisporivir

    CAS No.254435-95-5

  • Cyclosporin A

    CAS No.59865-13-3

  • Voclosporin

    CAS No.515814-01-4

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact